A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient
|
|
- William Barrett
- 5 years ago
- Views:
Transcription
1 Human Cytogenetics Case Report Cytogenet Genome Res 114:89 92 (2006) DOI: / A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient a b c d M.C. Varela A.C.V. Krepischi-Santos J.A. Paz J. Knijnenburg d b a K. Szuhai C. Rosenberg C.P. Koiffmann a Human Genome Study Center, and b Laboratory of Human Genetics, Department of Genetics and Evolutionary Biology, University of São Paulo, c Neurology Unit, Children Institute, University of São Paulo, School of Medicine, São Paulo (Brazil); d Laboratory of Cytochemistry and Cytometry, Department of Molecular Cell Biology, Leiden University Medical Center, Leiden (The Netherlands) Manuscript received 14 September 2005; accepted in revised form for publication by M. Schmid, 20 October Abstract. About 15% of patients with a clinical phenotype of Angelman syndrome (AS) have an unknown etiology. We report a patient with features reminiscent of AS, including a pattern of characteristic facial anomalies as well as speech impairment, developmental delay and frequent laughter. In addition, the patient had features not commonly associated with AS such as heart malformations and scoliosis. She was negative in SNURF-SNRPN exon 1 methylation studies and the G-banded karyotype was normal. Array-based comparative genomic hybridization disclosed a deletion of maximally 1 Mb at 17q The deleted region contains the MAPT gene, implicated in late onset neurodegenerative disorders, and the STH and NP_ genes. Another gene, such as CRHR1, might also be included based on maximum possible size of the deletion. We suggest that microdeletions within the 17q21.31 segment should be considered as a possible cause of phenotypes resembling AS, particularly when easily controlled seizures and/or cardiac abnormalities are also present. Copyright 2006 S. Karger AG, Basel Angelman syndrome (AS) (Angelman, 1965; Varela et al., 2004) is a neurobehavioral disease that comprises developmental delay, severe mental retardation, absent speech, seizures, ataxia, outbursts of laughter, microcephaly, brachycephaly, macrostomia and prognathism. Gait is described as wide-based, with arms held flexed and upheld at the elbows. Classical AS is caused by the loss of expression of maternally Supported by grants from the State of São Paulo Foundation for Support of Research (FAPESP) and the Brazilian National Foundation for Research (CNPq). Request reprints from Carla Rosenberg Departamento de Genética e Biologia Evolutiva, IB USP Rua do Matão, andar sala São Paulo, SP (Brazil) telephone: ; fax: Carlarosenberg45@aol.com M.C.V. and A.C.V.K.-S. contributed equally to this work. imprinted gene(s) mapped to the chromosome region 15q11]q13. Four different mechanisms are known to cause the AS phenotype: 70% have a maternal deletion within 15q11]q13; 2 3% exhibit paternal uniparental disomy of chromosome 15 (UPD15); 2% have a mutation in the imprinting center and 8% have mutations in the UBE3A gene. Additionally, 15% of AS cases have an, as yet, undetected genetic mechanism. We report a patient with features reminiscent of AS, and a microdeletion detected by array-based comparative genomic hybridization (array-cgh). Materials and methods Patient description Here we report a female patient first seen at 2 years of age who was referred for genetic testing for AS. Informed written consent was obtained from the parents. She was the first child born to non-consanguineous, healthy Caucasian parents at 38 weeks of gestation by Cesarean section. Birth weight was 2,560 g (2.5! P! 10), length was 44.5 cm Fax karger@karger.ch S. Karger AG, Basel /06/ $23.50/0 Accessible online at:
2 Results and discussion Fig. 1. Facial appearance of the propositus at the age of 2 (left) and 3 (right) years. ( P! 2.5) and OFC 34 cm (p25). Apgar scores were 9 at 1 min and 10 at 5 min. She presented poor sucking, neonatal hypotonia and mild developmental delay: she could raise her head at 6 months, sat without support at 8 months, walked at 19 months, and started to speak a few words around 2 years of age. At physical examination, she had brachycephaly, occipital groove, upslanting palpebral fissures, hypertelorism, anteverted nares, protruding tongue, micrognathia, prognathia, wide mouth, short philtrum, wide-spaced teeth, frequent drooling, strabismus, hypopigmented skin, light hair and eye color compared to family members ( Fig. 1 ). Her weight was 11.8 kg (25! P! 50 th centile), height 90 cm (75! P! 90 th centile), and head circumference 47.5 cm (50! P! 75 th centile). She also presented swallowing disorders, heart malformations including atrial septal and ventricular septal defects, and persistent ductus arteriosus, congenital left hip dislocation, scoliosis and impaired vision (hypermetropia). A single clonic seizure episode occurred at age of 13 months but a brain MRI was normal. She exhibited speech impairment with minimal use of words, non-verbal communication, frequent laughter and smiling with an apparently happy demeanor, excessive chewing/mouthing behavior, bruxism and attraction to/fascination with water. Array-CGH The array-cgh procedures were performed as previously described (Knijnenburg et al., 2005; Rosenberg et al., 2006). Briefly, slides containing triplicates of 3,500 large insert clones spaced at 1.0 Mb density over the full genome were produced in the Leiden University Medical Center. The large insert clone set used to produce these arrays was provided by the Wellcome Trust Sanger Institute (UK), and information regarding the full set is available at the Wellcome Trust Sanger Institute mapping database site, Ensembl ( DNA amplification, spotting on the slides and hybridization procedures were based on published protocols (Carter et al., 2002; Fiegler et al., 2003). Target imbalances were determined based on log2 ratios of the average of their replicates, and sequences were considered as amplified or deleted when outside the range. Fluorescence in situ hybridization (FISH) FISH experiments were performed on metaphase spreads from the patient to validate the presence of the imbalance identified by array- CGH analyses, and from her parents to determine if the deletion had been inherited. Clones shown to be deleted by array-cgh ( Fig. 2 ) were hybridized following standard procedures (Rosenberg et al., 1994). Analyses were performed under a Zeiss Axiophot epifluorescence microscope (Carl Zeiss, Jena, Germany). Metaphases were captured with a CCD camera and processed using ISIS software (MetaSystems, Altlussheim, Germany). The patient s karyotype after GTG-banding at the 550 band level resolution was 46,XX. The analysis of SNURF- SNRPN exon 1 methylation patterns amplified by PCR (Zeschnigk et al., 1997) showed one paternal and one maternal band, and excluded microdeletion of 15q11]q13, UPD and maternal mutation in the imprinting center as causes for the AS phenotype. Array-CGH was performed on DNA from peripheral blood from the patient as previously described (Rosenberg et al., 2006). Array clones found to be altered in normal controls or with a large standard deviation were excluded, as described in Rosenberg et al. (2005). The array-cgh disclosed a unique alteration, a deletion of Mb ( Fig. 2 A) at 17q21.31, which was confirmed by fluorescence in situ hybridization using the clone located in the deleted segment, namely RP5-843B9 (FISH Fig. 2 B). FISH on metaphases from the parents showed that the deletion of the patient was de novo. Mickelson et al. (1997) have reported a patient with a phenotype reminiscent of Angelman syndrome and a deletion mapped cytogenetically to the interval 17q23.1]q23.3. They used polymorphic markers to corroborate the supposed location of the cytogenetic deletion but surprisingly failed to show any loss of alleles. Recent information obtained from the Ensembl genome browser confirms that many of the markers used must have been within the cytogenetically determined deletion area. Those markers are physically located within the 17q22]q25 and cover over 22 Mb. Importantly, none of the informative markers would have overlapped the location of the deletion described by us, raising doubts on the accuracy of the estimated cytogenetic location of their deletion; this leaves open the possibility that their deletion could overlap ours. Further, Mickelson et al. (1997) compared their case to four other patients in the literature carrying 17q21]q24 deletions, none of whom exhibited resemblance to the Angelman phenotype. The deletion in our patient is much smaller and more precisely mapped than those described previously and reviewed by Mickelson et al. (1997). Amongst the features most frequently described in their review of patients with 17q21 deletions, our patient exhibited developmental delay, dislocated hips, impaired vision and congenital heart disease, but did not present short stature, microcephaly, symphalangism and proximal thumbs. Although our patient exhibits some features of AS, her developmental delay is milder and her seizures easier to control than generally observed in AS patients with 15q deletions, and is similar to some AS patients with UPD15. In addition, she does not present ataxic gait, characteristic of AS, and she has features not commonly found in AS such as congenital heart abnormalities and scoliosis. One other deletion patient detected by the same array- CGH probe (RP5-843B9) was recently reported by Shaw- Smith et al. (2004) in a screening for submicroscopic chromosome alterations in 50 patients with learning disabilities. It is noteworthy that the phenotype of their patient did not resemble AS, and includes short stature, mild contractures and 90 Cytogenet Genome Res 114:89 92 (2006)
3 Fig. 2. De novo deletion on chromosome 17 in the patient with Angelman syndrome phenotype. ( A ) Chromosome-17 array-cgh profile of the patient shows a deletion of a single clone at 17q The black line indicates the position of the deletion on the 17-ideogram. Underneath, an enlargement of the 17q21 band shows a map of the deleted and non-deleted flanking clones. ( B ) FISH of the clone RP5-843B9 to metaphase chromosomes of the patient s lymphocytes. The white arrows indicate the normal (left) and deleted (right) chromosomes 17. patchy skin pigmentation. The only feature in common with our patient was mental impairment. A critical comparison between the breakpoints of the deletions would provide a better understanding of the phenotypic effect of genes in the deleted areas. The segment on chromosome 17 encompassing the deletion in our patient harbors several low-copy repeats (LCR). These LCRs have been recently associated with a 900-kb inversion which is polymorphic with a high frequency (up to 20%) in European populations (Stefansson et al., 2005). This Cytogenet Genome Res 114:89 92 (2006) 91
4 region contains several genes, including the microtubule associated protein tau gene (MAPT), associated with late onset neurodegenerative disorders such as Alzheimer and the Parkinson-Dementia syndrome (MIM ). Other genes within the deleted clone are saitohin (STH), mainly expressed in placenta, muscle, and fetal and adult brains, and NP_ , with unknown function (Swiss-Prot/TrEMBL; The total possibly deleted area ( Fig. 2 A) contains other genes with known function, namely CRHR1 (expressed in cerebellum, cerebral cortex, pituitary and olfactory lobe), and NSF, expressed in the central nervous system and diminished in schizophrenic patients (Mirnics et al., 2000). Which genes in this area are involved in the phenotype of our patient remains to be determined. We suggest that deletion or alteration of one or more genes within this 1-Mb region should be considered as a possible genetic cause for patients resembling the AS phenotype and for whom the well known chromosome 15 mutational mechanisms for AS do not apply, particularly when mild neurodevelopment, easily controlled seizures and/or cardiac abnormalities are present. Acknowledgement We thank Peter L. Pearson for critical reading of the manuscript. References Angelman H: Puppet children A report on 3 cases. Develop Med Child Neurol 7: (1965). Carter NP, Fiegler H, Piper J: Comparative analysis of comparative genomic hybridization microarray technologies: report of a workshop sponsored by the Wellcome Trust. Cytometry 49: (2002). Ensembl: Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Smith J, et al: DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36: (2003). Knijnenburg J, Szuhai K, Giltay J, Molenaar L, Sloos W, Poot M, Tanke HJ, Rosenberg C: Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 132: (2005). Mickelson EC, Robinson WP, Hrynchak MA, Lewis ME: Novel case of del(17)(q23.1q23.3) further highlights a recognizable phenotype involving deletions of chromosome (17)(q21q24). Am J Med Genet 71: (1997). Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P: Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: (2000). Rosenberg C, Janson M, Nordeskjold M, Borresen AL, Vianna-Morgante AM: Intragenic reorganization of RB1 in a complex (4; 13) rearrangement demonstrated by FISH. Cytogenet Cell Genet 65: (1994). Rosenberg C, Knijnenburg J, Bakker E, Vianna-Morgante A, Sloos WC, Otto PA, et al: Array-CGH detection of micro rearrangements in mentally retarded individuals: Clinical significance of imbalances present both in affected children and normal parents. J Med Genet 43: (2006). Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, et al: Microarray based comparative genomic hybridisation (array-cgh) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 41: (2004). Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, et al: A common inversion under selection in Europeans. Nat Genet 37: (2005). Varela MC, Kok F, Otto PA, Koiffmann CP: Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects. Eur J Hum Genet 12: (2004). Zeschnigk M, Lich C, Buiting K, Doerfler W, Horsthemke B: A single-tube PCR test for the diagnosis of Angelman and Prader-Willi syndrome based on allelic methylation differences at the SNRPN locus. Eur J Hum Genet 5: (1997). 92 Cytogenet Genome Res 114:89 92 (2006)
5
6
Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects
(2004) 12, 987 992 & 2004 Nature Publishing Group All rights reserved 1018-4813/04 $30.00 www.nature.com/ejhg ARTICLE : comparison among different classes and between and UPD subjects Monica Castro Varela*,1,
More informationCHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
More informationDetermination of Genomic Imbalances by Genome-wide Screening Approaches
Overview Determination of Genomic Imbalances by Genome-wide Screening Approaches Károly Szuhai Introduction/Methodologies Applications/Results Conclusion Approaches Introduction/Methodologies Chromosome
More informationMultiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics
More informationFacts About AS. What is Angelman Syndrome
What is Angelman Syndrome In 1965, Dr. Harry Angelman, an English physician, first described three children with characteristics now known as the Angelman syndrome (AS). He noted that all had a stiff,
More informationChallenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014
Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,
More informationPhenotypic variability in Angelman syndrome report of two cases
Mædica - a Journal of Clinical Medicine CASE REPORTS Phenotypic variability in Angelman syndrome report of two cases Magdalena BUDISTEANU a,b, Aurora ARGHIR b, Georgeta CARDOS b, Sorina CHIRIEAC b, Sanda
More informationPrenatal Diagnosis: Are There Microarrays in Your Future?
Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?
More informationCYTOGENETICS Dr. Mary Ann Perle
CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided
More informationApplication of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation
Pediatr Neonatol 2008;49(6):213 217 REVIEW ARTICLE Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Jao-Shwann Liang 1,2 *, Keiko Shimojima
More informationCase 1B. 46,XY,-14,+t(14;21)
Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short
More informationSeven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott
Seven cases of intellectual disability analysed by genomewide SNP analysis Rodney J. Scott Ability to interrogate Genomic Material ~1930 Crude analyses 2012 Highly precise analyses A (very) brief history
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,
More informationR.C.P.U. NEWSLETTER. Hunting for Genes - It isn=t as easy as it looks! Angelman syndrome:
R.C.P.U. NEWSLETTER Editor: Heather J. Stalker, M.Sc. Director: Roberto T. Zori, M.D. R.C. Philips Research and Education Unit Vol. XII No. 1 A statewide commitment to the problems of mental retardation
More information22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)
22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases
More informationClinical evaluation of microarray data
Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray
More informationMolecular and clinical characterization of Angelman syndrome in Chinese patients
Clin Genet 2014: 85: 273 277 Printed in Singapore. All rights reserved Short Report 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12155 Molecular and
More informationSharan Goobie, MD, MSc, FRCPC
Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations
More informationSupplementary Clinical Information
Supplementary Clinical Information Patient 1 This female was born as the second child of a twin after a pregnancy duration of 32 weeks. The birth was otherwise uncomplicated and her twin brother was healthy.
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationApplications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه
More informationFaravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University
Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University 1395 21 مشاوره ژنتیک و نقش آن در پیش گیری از معلولیت ها 20
More informationCase Report Persistent Mosaicism for 12p Duplication/Triplication Chromosome Structural Abnormality in Peripheral Blood
Case Reports in Genetics Volume 2013, Article ID 857926, 4 pages http://dx.doi.org/10.1155/2013/857926 Case Report Persistent Mosaicism for 12p Duplication/Triplication Chromosome Structural Abnormality
More informationMOLECULAR MARKERS FOR DIAGNOSIS OF PRADER-WILLI SYNDROME IN THAI PATIENTS BY FISH
MOLECULAR MARKERS FOR PWS IN THAI PATIENTS MOLECULAR MARKERS FOR DIAGNOSIS OF PRADER-WILLI SYNDROME IN THAI PATIENTS BY FISH Sirilak Wiriyaukaradecha 1, Pimpicha Patmasiriwat 1, Pornswan Wasant 2 and Pornsri
More informationEuropean Journal of Medical Genetics 49 (2006) Original article
European Journal of Medical Genetics 49 (2006) 451 460 http://france.elsevier.com/direct/ejmg Original article Prader-Willi-like phenotype: investigation of 1p36 deletion in 41 patients with delayed psychomotor
More informationWhat s the Human Genome Project Got to Do with Developmental Disabilities?
What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the
More informationEpigenetics and Chromatin Remodeling
Epigenetics and Chromatin Remodeling Bradford Coffee, PhD, FACMG Emory University Atlanta, GA Speaker Disclosure Information Grant/Research Support: none Salary/Consultant Fees: none Board/Committee/Advisory
More informationWhen to suspect Prader Willi Syndrome and how to diagnose it?
When to suspect Prader Willi Syndrome and how to diagnose it? Dr Chirita-Emandi Adela Dr Dobrescu Andreea Victor Babes University of Medicine and Pahrmacy Timisoara Emergency Hospital for Children Louis
More informationA clinical follow-up of 35 Brazilian patients with Prader- Willi Syndrome
DOI:10.6061/clinics/2012(08)11 CLINICAL SCIENCE A clinical follow-up of 35 Brazilian patients with Prader- Willi Syndrome Caio Robledo D Angioli Costa Quaio, I Tatiana Ferreira de Almeida, I Lilian Maria
More informationMLPA SAMPLES USER GUIDE
MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple
More informationCanadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
More informationCase Report Genotype-Phenotype Characterization of Wolf-Hirschhorn Syndrome Confirmed by FISH: Case Reports
Case Reports in Genetics Volume 2012, Article ID 878796, 5 pages doi:10.1155/2012/878796 Case Report Genotype-Phenotype Characterization of Wolf-Hirschhorn Syndrome Confirmed by FISH: Case Reports F. Sheth,
More informationAssociation for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:
More informationCopy number imbalances detected with a BAC-based array comparative genomic hybridization platform in congenital diaphragmatic hernia fetuses
Copy number imbalances detected with a BAC-based array comparative genomic hybridization platform in congenital diaphragmatic hernia fetuses I.N. Machado 1,2, J.K. Heinrich 2, R. Barini 1 and C.F.A. Peralta
More informationApproach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD
Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance
More informationChromosome 15 Introduction
Chromosome 15 Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University
More informationCase Report Severe Psychomotor Delay in a Severe Presentation of Cat-Eye Syndrome
Case Reports in Genetics Volume 2015, Article ID 943905, 4 pages http://dx.doi.org/10.1155/2015/943905 Case Report Severe Psychomotor Delay in a Severe Presentation of Cat-Eye Syndrome Guillaume Jedraszak,
More informationMRC-Holland MLPA. Description version 52; 22 July 2015
SALSA MS-MLPA probemix ME028-B2 Prader-Willi/Angelman Lot B2-0413, lot B2-0811. As compared to version B1 (lot B1-0609), the control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME (PWS) and
More informationPRADER WILLI/ANGELMAN
SALSA MS-MLPA probemix ME028-B2 PRADER WILLI/ANGELMAN Lot B2-0811: As compared to version B1 (lot B1-0609, B1-1108), the 88 and 96 nt control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME
More informationApproach to the Genetic Diagnosis of Neurological Disorders
Approach to the Genetic Diagnosis of Neurological Disorders Dr Wendy Jones MBBS MRCP Great Ormond Street Hospital for Children National Hospital for Neurology and Neurosurgery What is a genetic diagnosis?
More informationInternational Journal of Pharma and Bio Sciences NEUROLOGICAL AND CLINICAL ASPECTS OF ANGELMAN SYNDROME, A NEURO-GENETIC DISORDER
International Journal of Pharma and Bio Sciences NEUROLOGICAL AND CLINICAL ASPECTS OF ANGELMAN SYNDROME, A NEURO-GENETIC DISORDER SATYANAND TYAGI*, MOHIT SINGLA AND SACHIN KUMAR. K.N.G.D Modi Institute
More informationLab Activity 36. Principles of Heredity. Portland Community College BI 233
Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of
More informationMost severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).
SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:
More informationCytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
More informationEvolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University
Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome
More informationNew and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads
New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor
More informationGenerating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University
Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic
More informationAn International System for Human Cytogenetic Nomenclature (2013)
ISCN 2013 An International System for Human Cytogenetic Nomenclature (2013) Editors Lisa G. Shaffer Jean McGowan-Jordan Michael Schmid Recommendations of the International Standing Committee on Human Cytogenetic
More informationGenetic Testing for Single-Gene and Multifactorial Conditions
Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents
More informationAn Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013
An Overview of Cytogenetics Bridget Herschap, M.D. 9/23/2013 Objectives } History and Introduction of Cytogenetics } Overview of Current Techniques } Common cytogenetic tests and their clinical application
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Manchester RGC Approved: September 2013
More informationSyndromic X Linked Mental Retardation
Syndromic X Linked Mental Retardation Introduction : Dr. Yousef.A. Assaleh Dept. of Pediatric - faculty of medicine Zawia University Mental retardation is defined as incomplete or insufficient general
More informationStructural Chromosome Aberrations
Structural Chromosome Aberrations 2 Structural chromosome aberrations or chromosome mutations represent apart from aneuploidies the most frequent pathologic findings in applied chromosome diagnostics.
More informationSupplementary Note. Phenotype details in ten patients with deletions of 15q13
Supplementary Note. Phenotype details in ten patients with deletions of 15q13 IMR338, IMR338M, and IMR338Cc familial 3.95 Mb deletion BP3-BP5 The proband, IMR338, was initially reported by Sharp et al.
More informationClinical Spectrum and Molecular Diagnosis of Angelman and Prader-Willi Syndrome Patients With an Imprinting Mutation
American Journal of Medical Genetics 68:195 206 (1997) Clinical Spectrum and Molecular Diagnosis of Angelman and Prader-Willi Syndrome Patients With an Imprinting Mutation Shinji Saitoh, 1 Karin Buiting,
More informationSupplementary note: Comparison of deletion variants identified in this study and four earlier studies
Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Here we compare the results of this study to potentially overlapping results from four earlier studies
More informationChromosome Microarray Analysis (CMA)
Chromosome Microarray Analysis (CMA) Ina E. Amarillo, PhD FACMG Cytogenomics Lab (Associate Medical Director) Pathology (Assistant Professor) OUTLINE Clinical Indications for Cytogenomics Testing Cytogenomics
More informationChildren s Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.
Multiplex ligation-dependent probe amplification (MLPA) genetic testing in the diagnostics of children with developmental delay/intellectual disabilities Leona Morožin Pohovski, Ingeborg Barišid Children
More informationProtocol. Genetic Testing for Developmental Delay and Autism Spectrum Disorder
Genetic Testing for Developmental Delay and Autism Spectrum (20459, 20483, 20481) Medical Benefit Effective Date: 01/01/18 Next Review Date: 09/18 Preauthorization Yes Review Dates: 09/10, 09/11, 03/12,
More informationAssessment of clinical scoring systems for the diagnosis of Williams-Beuren syndrome
Short Communication Assessment of clinical scoring systems for the diagnosis of Williams-Beuren syndrome D.E.S. Leme 1, D.H. Souza 1, G. Mercado 2, E. Pastene 2, A. Dias 3 and D. Moretti-Ferreira 1 1 Serviço
More informationHigh resolution melting for methylation analysis
High resolution melting for methylation analysis Helen White, PhD Senior Scientist National Genetics Reference Lab (Wessex) Why analyse methylation? Genomic imprinting In diploid organisms somatic cells
More informationGenomic structural variation
Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural
More informationGenetic Testing 101: Interpreting the Chromosomes
Genetic Testing 101: Interpreting the Chromosomes Kristin Lindstrom, MD Division of Genetics and Metabolism Phoenix Children s Hospital AzAAP Pediatrics in the Red Rocks I have no disclosures for this
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Single Nucleotide Polymorphism (SNP) Chromosomal Microarray Analysis for Prenatal Testing and Intellectual Disability, Developmental Delay, and Multiple
More informationSupplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our
1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented
More informationEpigenetic contribution to birth defects. David Amor 20 th June 2011
Epigenetic contribution to birth defects David Amor 20 th June 2011 Genomic imprinting Genomic imprinting is the biological process whereby a gene or genomic domain is biochemically marked with information
More informationGlobal variation in copy number in the human genome
Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)
More informationCopy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory
Copy Number Variants of Uncertain Significance in Prenatal diagnosis Are the Goalposts Moving? Lisa Burvill-Holmes Bristol Genetics Laboratory http://www.nbt.nhs.uk/genetics Microarray CGH in Prenatal
More informationCGH microarray studies in idiopathic developmental/ cognitive impairment: association of historical and clinical features and the De Vries Score
Clinical science Acta Medica Academica 2011;40(1):17-26 DOI 10.5644/ama2006-124.4 CGH microarray studies in idiopathic developmental/ cognitive impairment: association of historical and clinical features
More informationGenetic Assessment and Counseling
Genetic Assessment and Counseling Genetic counseling is the communication of information and advice about inherited conditions and a person seeking such advice is called a consultand. This process includes
More informationGenetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies
Genetic Testing for the Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies Policy Number: 2.04.59 Last Review: 5/2018 Origination: 5/2015 Next Review: 5/2019
More informationUnusual Modes of Inheritance. Wayne Lam
Unusual Modes of Inheritance Wayne Lam wayne.lam@ed.ac.uk New Genetics Non-Mendelian Genomic Imprinting Digenic Inheritance Triallelic inheritance Mitochondrial Inheritance Chromosomal Telomeric deletions
More informationTagawa, Masato; Harada, Naoki; Mori. is available at
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Mirror duplication of chromosome 21 syndrome. Egashira, Masanori; Kondoh, Tatsuro Tagawa, Masato; Harada, Naoki; Mori Pediatrics international,
More informationCNV Detection and Interpretation in Genomic Data
CNV Detection and Interpretation in Genomic Data Benjamin W. Darbro, M.D., Ph.D. Assistant Professor of Pediatrics Director of the Shivanand R. Patil Cytogenetics and Molecular Laboratory Overview What
More informationSotos syndrome. Nazneen Rahman Institute of Cancer Research
Sotos syndrome Nazneen Rahman Institute of Cancer Research Sotos syndrome- background Sporadic condition Distinctive facial appearance Overgrowth (tall with big heads) Learning difficulties Other variably
More informationMicrodeletion and Prenatal FISH Probes
Microdeletion and Prenatal FISH Probes Rapid Prenatal Screening The Cytocell prenatal FISH assays are designed for the rapid and accurate detection of the most common foetal chromosomal disorders: Down
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationA rare case of a boy with de novo microduplication at 5q35.2q35.3 from central Brazil
A rare case of a boy with de novo microduplication at 5q35.2q35.3 from central Brazil F.G. Reis 1,4, I.P. Pinto 2,4, L.B. Minasi 3,4, A.V. Melo 2,4, D.M. da C. Cunha 4, C.L. Ribeiro 2,4, C.C. da Silva
More informationDr Dipti Deshmukh. Mayu Uemura. 11th September Introduction
Genetic Findings in Children with Unexplained Developmental Delay Dr Dipti Deshmukh Neurodevelopmental Consultant, St. George's Hospital, London Mayu Uemura 4th year MBBS4, St George s University of London
More informationPRADER-WILLI SYNDROME HOWARD WONG 3UU PER. 6 GENETICS SBS11QHG2 #24
PRADER-WILLI SYNDROME HOWARD WONG 3UU PER. 6 GENETICS SBS11QHG2 #24 PHYSIOLOGY Fig. 1 Fig. 2 Prader-Willi Syndrome affects both the physical and mental state of a person, starting from birth until the
More informationInterstitial deletions of chromosome 6q: genotype phenotype correlation utilizing array CGH
Clin Genet 2007: 71: 260 266 Printed in Singapore. All rights reserved Short Report # 2007 The Authors Journal compilation # 2007 Blackwell Munksgaard CLINICAL GENETICS doi: 10.1111/j.1399-0004.2007.00757.x
More informationSNP Microarray. Prenatal
SNP Microarray Prenatal SNP Microarray Reveal SNP Microarray is a test that analyzes chromosomes for changes that can explain certain kinds of birth defects. This brochure is designed to answer some of
More informationGenome-wide analysis by SNP Array
Genome-wide analysis by SNP Array SNP Array in the diagnosis of Mental Retardation and Congenital Abnormalities Contents Introduction...3 Conventional and molecular cytogenetics (FISH)...4 1. Karyotyping...4
More informationEarly detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases
Horváth et al. Molecular Cytogenetics 2013, 6:35 CASE REPORT Open Access Early detection of Angelman syndrome resulting from de novo paternal isodisomic 15q UPD and review of comparable cases Emese Horváth
More informationProduct Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.
Product Description SALSA MS- Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol. Version C1. For complete product history see page 9. Catalogue numbers: ME028-025R: SALSA
More informationClinical Genomics. Ina E. Amarillo, PhD FACMGG
Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing
More informationSection: Medicine Effective Date: January15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 7, 2011 Subject:
Section: Medicine Effective Date: January15, 2016 Last Review Status/Date: December 2015 Page: 1 of 22 Microarray Analysis and Next-Generation Autism Spectrum Disorder and/or Congenital Description Chromosomal
More informationDanielius Serapinas*
e - ISSN - 2349-8005 INTERNATIONAL JOURNAL OF ADVANCES IN CASE REPORTS Journal homepage: www.mcmed.us/journal/ijacr PRADER -WILLI SYNDROME : CASE REPORT AND LITERATURE REVIEW Danielius Serapinas* Mykolas
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationDelimitation of Duplicated Segments and Identification of Their Parental Origin in Two Partial Chromosome 3p Duplications
American Journal of Medical Genetics 113:144 150 (2002) Delimitation of Duplicated Segments and Identification of Their Parental Origin in Two Partial Chromosome 3p Duplications Sylvie Antonini, 1 Chong
More informationC linical geneticists are notorious jargon
1264 REVIEW Chromosome analysis: what and when to request F H Sharkey, E Maher, D R FitzPatrick... Chromosome abnormalities have long been recognised as an important cause of learning disability and multiple
More informationreview Genetics IN Medicine 13
January 2008 Vol. 10 No. 1 review Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives Sandra Darilek, MS, Patricia Ward, MS, Amber Pursley, MS,
More informationInvestigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies
Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies Akbar Mohammadzadeh MD, PhD candidate in Medical Genetics Genetics Research Center University
More informationC hromosomal anomalies account for a substantial
166 LETTER TO JMG Tiling path resolution mapping of constitutional 1p36 deletions by array-cgh: contiguous gene deletion or deletion with positional effect syndrome? R Redon, M Rio, S G Gregory, R A Cooper,
More informationPractical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and
More informationMRC-Holland MLPA. Description version 29; 31 July 2015
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082
More informationShort Report. B Lakhal a, R Braham b, R Berguigua a, N Bouali a, M Zaouali c, M Chaieb b, RA Veitia d,e,f, A Saad a,g and H Elghezal a,g
Clin Genet 2010: 78: 181 185 Printed in Singapore. All rights reserved Short Report 2010 John Wiley & Sons A/S CLINICAL GENETICS doi: 10.1111/j.1399-0004.2009.01359.x Cytogenetic analyses of premature
More information